These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 21606622
1. Neuropsychotoxic and neuroprotective potentials of dextromethorphan and its analogs. Shin EJ, Bach JH, Lee SY, Kim JM, Lee J, Hong JS, Nabeshima T, Kim HC. J Pharmacol Sci; 2011; 116(2):137-48. PubMed ID: 21606622 [Abstract] [Full Text] [Related]
2. Neuropsychotoxicity of abused drugs: potential of dextromethorphan and novel neuroprotective analogs of dextromethorphan with improved safety profiles in terms of abuse and neuroprotective effects. Shin EJ, Lee PH, Kim HJ, Nabeshima T, Kim HC. J Pharmacol Sci; 2008 Jan; 106(1):22-7. PubMed ID: 18198471 [Abstract] [Full Text] [Related]
3. Neuropsychopharmacological understanding for therapeutic application of morphinans. Shin EJ, Hong JS, Kim HC. Arch Pharm Res; 2010 Oct; 33(10):1575-87. PubMed ID: 21052935 [Abstract] [Full Text] [Related]
4. Concise synthesis of dimemorfan (DF) starting from 3-hydroxymorphinan (3-HM). Kim JY, Kim HC, Kim J, Lee J. Chem Pharm Bull (Tokyo); 2008 Jul; 56(7):985-7. PubMed ID: 18591815 [Abstract] [Full Text] [Related]
5. Dextromethorphan analogs are neuroprotective in vitro and block glutamate-induced excitotoxic calcium signals in neurons. Tortella FC, Klette KL, DeCoster MA, Davis BJ, Newman AH. Neurosci Lett; 1995 Sep 29; 198(2):79-82. PubMed ID: 8592646 [Abstract] [Full Text] [Related]
6. Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan. Chou YC, Liao JF, Chang WY, Lin MF, Chen CF. Brain Res; 1999 Mar 13; 821(2):516-9. PubMed ID: 10064839 [Abstract] [Full Text] [Related]
8. Effects of dextrorotatory morphinans on brain Na+ channels expressed in Xenopus oocytes. Lee JH, Shin EJ, Jeong SM, Lee BH, Yoon IS, Lee JH, Choi SH, Kim YH, Pyo MK, Lee SM, Chae JS, Rhim H, Oh JW, Kim HC, Nah SY. Eur J Pharmacol; 2007 Jun 14; 564(1-3):7-17. PubMed ID: 17346698 [Abstract] [Full Text] [Related]
10. Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action. Werling LL, Lauterbach EC, Calef U. Neurologist; 2007 Sep 14; 13(5):272-93. PubMed ID: 17848867 [Abstract] [Full Text] [Related]
11. Synthesis and evaluation of 3-substituted 17-methylmorphinan analogs as potential anticonvulsant agents. Newman AH, Bevan K, Bowery N, Tortella FC. J Med Chem; 1992 Oct 30; 35(22):4135-42. PubMed ID: 1433216 [Abstract] [Full Text] [Related]
13. Dimemorfan prevents seizures induced by the L-type calcium channel activator BAY k-8644 in mice. Shin EJ, Nabeshima T, Lee PH, Kim WK, Ko KH, Jhoo JH, Jhoo WK, Cha JY, Kim HC. Behav Brain Res; 2004 May 05; 151(1-2):267-76. PubMed ID: 15084442 [Abstract] [Full Text] [Related]
18. New morphinan derivatives with negligible psychotropic effects attenuate convulsions induced by maximal electroshock in mice. Kim HC, Shin CY, Seo DO, Jhoo JH, Jhoo WK, Kim WK, Shin EJ, Lee YH, Lee PH, Ko KH. Life Sci; 2003 Mar 07; 72(16):1883-95. PubMed ID: 12586225 [Abstract] [Full Text] [Related]
20. Inhibitory effect of glutamate release from rat cerebrocortical synaptosomes by dextromethorphan and its metabolite 3-hydroxymorphinan. Lin TY, Lu CW, Wang SJ. Neurochem Int; 2009 Jul 07; 54(8):526-34. PubMed ID: 19428798 [Abstract] [Full Text] [Related] Page: [Next] [New Search]